Sepsis

Sepsis – High‑Yield Study Guide for Medical Students

Definition

Sepsis is defined as life‑threatening organ dysfunction caused by a dysregulated host response to infection. The current international Sepsis‑3 consensus uses an increase in the Sequential Organ Failure Assessment (SOFA) score of ≥2 points from baseline, in the context of suspected or documented infection, to define sepsis. Septic shock is a subset of sepsis with profound circulatory and cellular/metabolic abnormalities associated with a greater risk of mortality, characterized by persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) ≥65 mmHg and serum lactate >2 mmol/L despite adequate fluid resuscitation.

Epidemiology

Sepsis is a major global cause of morbidity and mortality, affecting millions of patients annually and representing a leading cause of death in intensive care units. Incidence increases with age, comorbidities (e.g., diabetes, malignancy, chronic organ dysfunction), and immunosuppression. Common sources include pneumonia, intra‑abdominal infections, urinary tract infections, skin and soft tissue infections, and catheter‑related bloodstream infections.

Pathophysiology

Sepsis results from a complex interplay between the invading pathogen and the host immune response, leading to an imbalanced pro‑inflammatory and anti‑inflammatory cascade. Pathogen‑associated molecular patterns (PAMPs) such as endotoxin (LPS) and damage‑associated molecular patterns (DAMPs) activate pattern recognition receptors (e.g., Toll‑like receptors) on immune cells. This triggers release of cytokines (e.g., TNF‑α, IL‑1, IL‑6), complement activation, and coagulation pathway upregulation.

The downstream consequences include endothelial injury, capillary leak, vasodilation, microvascular thrombosis, and impaired oxygen delivery to tissues. Mitochondrial dysfunction and cellular metabolic derangements contribute to organ failure. The coagulation system becomes activated with impaired anticoagulant pathways and suppressed fibrinolysis, predisposing to disseminated intravascular coagulation (DIC). In later phases, an excessive compensatory anti‑inflammatory response may lead to immune paralysis and increased susceptibility to secondary infections.

Clinical Presentation

Clinical manifestations of sepsis are highly variable and depend on both the source of infection and the degree of organ dysfunction. Early recognition requires a high index of suspicion in any acutely ill patient with infection risk.

Common Symptoms and Signs

• Systemic symptoms: fever or hypothermia, chills, rigors, malaise, myalgias.
• Cardiovascular: tachycardia, hypotension, warm or cool extremities, delayed capillary refill.
• Respiratory: tachypnea, dyspnea, hypoxia; may progress to acute respiratory distress syndrome (ARDS).
• Neurologic: confusion, agitation, decreased level of consciousness, delirium.
• Renal: oliguria or anuria, rising creatinine.
• Hepatic: jaundice, elevated transaminases, coagulopathy.
• Hematologic: leukocytosis or leukopenia, thrombocytopenia, bleeding or bruising (suggesting DIC).
• Metabolic: hyperglycemia, metabolic acidosis, elevated lactate.

Source‑Specific Features

• Pulmonary: cough, sputum, pleuritic chest pain, abnormal lung exam, infiltrates on chest imaging.
• Urinary tract: dysuria, frequency, flank pain, costovertebral angle tenderness.
• Intra‑abdominal: abdominal pain, distension, peritonitis, vomiting, absent bowel sounds.
• Skin/soft tissue: cellulitis, erythema, abscess, crepitus (necrotizing infections).
• Catheter/line related: erythema or purulence at insertion site, unexplained bacteremia.

Diagnosis

Diagnosis of sepsis requires recognition of infection plus new organ dysfunction. No single test is diagnostic; it is a clinical diagnosis supported by laboratory, microbiologic, and imaging data.

Screening and Criteria

• Suspected or confirmed infection based on history, exam, imaging, and microbiology.
• SOFA score: an increase ≥2 points from baseline indicates sepsis; it includes PaO₂/FiO₂, platelet count, bilirubin, MAP/vasopressors, Glasgow Coma Scale (GCS), and creatinine/urine output.
• qSOFA (quick SOFA) bedside screen: respiratory rate ≥22/min, altered mentation (GCS <15), systolic BP ≤100 mmHg; ≥2 suggests increased risk of poor outcome and prompts further evaluation.
• Traditional SIRS criteria (temperature, heart rate, respiratory rate, WBC) are less specific but still widely used for early screening.

Laboratory Evaluation

• Basic labs: CBC with differential, CMP, coagulation profile, arterial or venous blood gas, lactate.
• Markers of infection: elevated or depressed WBC, increased C‑reactive protein (CRP), procalcitonin (may assist with diagnosis and antibiotic stewardship but is not definitive on its own).
• Organ dysfunction indicators:
  • Renal: elevated creatinine, reduced urine output.
  • Hepatic: elevated bilirubin, transaminases.
  • Hematologic: thrombocytopenia, elevated INR/PTT, D‑dimer (DIC).
  • Metabolic: elevated lactate >2 mmol/L, metabolic acidosis.

Microbiology and Imaging

• Blood cultures: obtain at least two sets (aerobic and anaerobic) from different sites prior to antibiotics when feasible, without delaying therapy.
• Cultures from suspected source: urine, sputum, wound, catheter tip, CSF, or other site‑specific samples.
• Imaging: chest X‑ray, ultrasound, CT, MRI as indicated to identify source, complications (abscess, empyema), and need for source control.

Management

Management of sepsis is time‑critical and centers on early recognition, rapid hemodynamic resuscitation, appropriate antimicrobials, and definitive source control. Many aspects are guided by the Surviving Sepsis Campaign recommendations and local protocols.

Initial Resuscitation (First Hour Bundle)

• Assess and secure airway and breathing: provide supplemental oxygen; consider early intubation and mechanical ventilation for respiratory failure, severe work of breathing, or altered mental status.
• Circulation:
  • Establish IV access (ideally two large‑bore peripheral lines; central access as needed).
  • Measure lactate level; repeat lactate within 2–4 hours if initially elevated.
  • Administer rapid fluid resuscitation with 30 mL/kg crystalloid (e.g., balanced crystalloid or normal saline) within the first 3 hours for hypotension or lactate ≥4 mmol/L, unless contraindicated.
• Antibiotics:
  • Obtain blood cultures before antibiotics if this does not significantly delay therapy.
  • Administer broad‑spectrum IV antibiotics within 1 hour of recognition of sepsis or septic shock, targeting likely pathogens and source (e.g., piperacillin‑tazobactam, cefepime plus vancomycin, or carbapenem in high‑risk settings; adjust per local resistance patterns).
  • De‑escalate antibiotics based on culture results and clinical course.

Hemodynamic Support

• Fluid therapy:
  • Reassess hemodynamic status frequently (MAP, urine output, mental status, lactate trend, dynamic measures of fluid responsiveness).
  • Use additional fluid boluses guided by bedside assessment rather than fixed volumes after initial resuscitation.
• Vasopressors:
  • Initiate vasopressors if hypotension persists after adequate fluid resuscitation to maintain MAP ≥65 mmHg.
  • Norepinephrine is the first‑line vasopressor. Add vasopressin or epinephrine if needed for refractory shock.
  • Consider invasive arterial blood pressure monitoring in patients on vasopressors.
• Inotropes:
  • Consider dobutamine in patients with myocardial dysfunction or persistently low cardiac output despite adequate filling and MAP.

Source Control

• Identify and control the infectious source as early as possible (ideally within 6–12 hours).
• Approaches include drainage of abscesses, debridement of necrotic tissue, removal of infected catheters or devices, and surgical interventions for intra‑abdominal or soft tissue infections.

Adjunctive Therapies

• Corticosteroids:
  • Consider IV hydrocortisone (e.g., 200 mg/day) in patients with septic shock unresponsive to adequate fluids and vasopressors.
• Glycemic control:
  • Maintain blood glucose typically <180 mg/dL with insulin therapy if needed, avoiding hypoglycemia.
• Transfusion:
  • Transfuse packed RBCs if hemoglobin <7 g/dL in stable patients; consider higher thresholds in active bleeding, myocardial ischemia, or severe hypoxemia.
• Renal replacement therapy:
  • Initiate in cases of refractory hyperkalemia, severe metabolic acidosis, fluid overload, or uremic complications.
• Ventilatory support:
  • For ARDS, use lung‑protective mechanical ventilation strategies (low tidal volumes, appropriate PEEP) and conservative fluid management.

Monitoring and Ongoing Care

• Continuous monitoring of vital signs, urine output, mental status, and perfusion parameters.
• Serial labs including lactate, renal and liver function tests, and coagulation parameters.
• Daily reassessment of the need for invasive devices (lines, catheters), sedation, and mechanical ventilation.
• Early mobilization and nutrition support (enteral preferred) as soon as clinically feasible.

Key Clinical Pearls for Medical Students

• Think sepsis early: any acutely ill patient with suspected infection plus new organ dysfunction should be evaluated for sepsis. Early recognition dramatically impacts outcomes.
• Time‑critical interventions: early antibiotics (within 1 hour), fluid resuscitation, and source control are central to improving survival.
• Use structured tools: understand how to calculate and interpret SOFA and qSOFA; recognize that SIRS criteria are sensitive but nonspecific.
• Lactate matters: an elevated lactate suggests tissue hypoperfusion and is associated with worse prognosis; trending lactate helps guide resuscitation.
• Hypotension is late: patients, especially the elderly or on beta‑blockers, may have sepsis without classic tachycardia or hypotension; look for subtle changes such as confusion or reduced urine output.
• Broad then narrow: start empiric broad‑spectrum coverage based on likely source and local resistance, then de‑escalate when culture and sensitivity data return.
• Fluids and vasopressors are complementary: resuscitation is not fluid versus vasopressors but the right balance of both, guided by hemodynamic assessment.
• Source control is definitive: antibiotics alone may be insufficient without drainage or surgical management when an abscess, necrotizing infection, or perforation is present.
• Sepsis is dynamic: patients can deteriorate rapidly; frequent reassessment is crucial, especially in the first 24–48 hours.
• Think long‑term: survivors may experience post‑sepsis syndrome with physical, cognitive, and psychological sequelae; early rehabilitation and follow‑up are important.

Summary

Sepsis is a life‑threatening organ dysfunction driven by a dysregulated host response to infection. Medical students should be able to recognize its clinical features, apply SOFA and qSOFA, interpret key labs such as lactate, and understand the principles of early goal‑directed resuscitation, timely antibiotics, and source control. Mastery of these fundamentals is vital in any acute care setting and forms the backbone of safe, effective management of critically ill patients.